Dr. David Fajgenbaum has almost died five times from Castleman disease, a group of rare and deadly disorders of the lymph nodes. After his diagnosis upended his plans for a more conventional medical career, “Think It, Do It” became his motto. He decided to dedicate his professional life to not only working towards a cure for Castleman as a physician-scientist, but also cofounding and managing the Castleman Disease Collaborative Network (CDCN) — a research collective to disrupt the broken, disorganized approach to disease research. David pursued and earned an MBA in the process to better tackle the complex, often contradictory web of medical and pharmaceutical research, regulation, and care.
HBR Presents is a network of podcasts curated by HBR editors, bringing you the best business ideas from the leading minds in management. The views and opinions expressed are solely those of the authors and do not necessarily reflect the official policy or position of Harvard Business Review or its affiliates.
via HBR.org https://ift.tt/2pDjAZm